CLINICAL_TRIALS
ClinicalTrials.gov record update
A Pilot Study of FOLFOX in Combination With Bevacizumab in Patients With Advanced Neuroendocrine Tumors
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00227617
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:09.218925+00:00
- Published At
- 2019-12-26T00:00:00+00:00
- Record Updated At
- 2023-05-22
- Results Posted At
- 2019-12-26
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Gastrointestinal Carcinoid Tumor", "Islet Cell Tumor", "Lung Cancer", "Neoplastic Syndrome", "Neuroendocrine Tumor"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-05-22"- protocolSection.identificationModule.nctId
"NCT00227617"- protocolSection.identificationModule.officialTitle
"A Pilot Study of FOLFOX in Combination With Bevacizumab in Patients With Advanced Neuroendocrine Tumors"- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["PHASE2", "PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2019-12-26"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.